Delayed identification of cobalt toxicity may result in poor recovery and significant morbidity. These include cardiomyopathy, peripheral neuropathy, vision loss, and chronic respiratory disease. Cobalt metal without tungsten carbide is classified by the International Agency for Research on Cancer (IARC) as Group 2B (possibly carcinogenic to humans).

Cobalt in the setting of tungsten carbide is classified as Group 2A (probably carcinogenic to humans).